We have been retained by our biopharmaceutical client that has a Generics Division to identify a Sales Director. This individual must possess pharmaceutical generic sales experience, and must be a self-starter, quality-driven, detail-oriented person who can get things done to fill this management role. One will provide input into the development and management of both short and long term marketing strategies to drive sales and growth as well as manage key national accounts for the generics division for our client.

This Associate Director search is being conducted on behalf of our Medical Device client who has FDA approval for the treatment of depression. This treatment has the CE mark of approval and is used globally.

This individual will be responsible for the management and oversight of clinical studies or clinical projects. One will conduct clinical studies including protocol, site selection, data collection to finalization of clinical study reports, and development of study related documents.

We have been retained by our biopharmaceutical client that has a Generics Business to identify a Business Development Analyst Senior Manager/Director. This individual must possess pharmaceutical generic drug business development and market analysis experience, experience working on programs focusing on the development of generic pharmaceutical products. This includes analyzing market share, business development opportunities and identifying competitors of the company and formulating sales forecast plans.

We have been retained by our client to hire a Director Scientific Affairs & Evidence Generation. Our client has identified a gap and expertise and needs the expertise of an MD or PhD to help develop high level strategic clinical development plans for products from conception through reimbursement and post market needs. They have successful achieved a marketed oncology product and have a full pipeline. The goal is to develop strategies on clinical evidence development. This is not about executing a protocol but about setting the strategy and being able to know what goes into the protocol, know how it is structured to assure that patient enrollment will work and that they can access the patients in a reasonable time-frame during the care of their journey.

We have been retained by our biopharmaceutical client to identify a Business Development Senior Manager to search and evaluate therapeutic drugs to acquire or in-license. An emphasis will be on identifying innovative drugs that treat cancers and liver diseases.

Our client is focused on the acquisition, development, and commercialization of quality pharmaceuticals and innovative therapeutics addressing cancer and other unmet medical needs for the global market. They have a strong and growing product pipeline of commercially available and clinical stage drug candidates.

We have been retained by our biopharmaceutical client to identify a Business Development Senior Manager to search and evaluate therapeutic drugs to acquire or in-license. An emphasis will be on identifying innovative drugs that treat cancers and liver diseases.

Our client is focused on the acquisition, development, and commercialization of quality pharmaceuticals and innovative therapeutics addressing cancer and other unmet medical needs for the global market. They have a strong and growing product pipeline of commercially available and clinical stage drug candidates.

We have been retained to hire a Medical Affairs Director/Senior Director Neurology. This individual will be the "CEO" of a pre-launched product, building the Medical Affairs plans for the Neurology Phase III asset. One must have strong launch experience, a proven track record of success in the biotechnology or pharmaceutical industry and a solid background in Medical Affairs and Neurology. A well-organized individual with the ability to develop project strategies and execute project details and has strong working relationships with key thought leaders, medical communications and support of colleagues in internal departmental functions. This is a dynamic, fast-paced team environment.

We have been engaged by our biopharmaceutical client to expand their existing MSL team for another launch set for 2020. This is yet another Rare Disease asset.

They currently have 3 marketed products and a very robust pipeline from Preclinical to Phase III.

This launch will be their 4th product to hit the market making a difference in the lives of patients.

The total MSL team will be 10 which allows you the uniqueness of working across therapeutic areas and having a diverse disease portfolio within the Rare Disease space.